UBS Group’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26K | Sell |
32,513
-29,556
| -48% | -$23.6K | ﹤0.01% | 6967 |
|
|
2025
Q1 | $57K | Sell |
62,069
-83,049
| -57% | -$76.2K | ﹤0.01% | 6195 |
|
|
2024
Q4 | $138K | Buy |
+145,118
| New | +$138K | ﹤0.01% | 5476 |
|
|
2024
Q2 | – | Sell |
-7,678
| Closed | -$11.7K | – | 8381 |
|
|
2024
Q1 | $11.7K | Buy |
+7,678
| New | +$11.7K | ﹤0.01% | 5994 |
|
|
2023
Q3 | – | Sell |
-2,509
| Closed | -$2.81K | – | 8333 |
|
|
2023
Q2 | $2.81K | Sell |
2,509
-3,649
| -59% | -$4.09K | ﹤0.01% | 6606 |
|
|
2023
Q1 | $6.4K | Buy |
+6,158
| New | +$6.4K | ﹤0.01% | 6827 |
|
|
2022
Q4 | – | Sell |
-4,599
| Closed | -$5K | – | 9531 |
|
|
2022
Q3 | $5K | Buy |
4,599
+4,159
| +945% | +$4.52K | ﹤0.01% | 8069 |
|
|
2022
Q2 | $0 | Sell |
440
-3,004
| -87% | – | ﹤0.01% | 9291 |
|
|
2022
Q1 | $8K | Sell |
3,444
-6,693
| -66% | -$15.5K | ﹤0.01% | 7602 |
|
|
2021
Q4 | $28K | Buy |
10,137
+3,359
| +50% | +$9.28K | ﹤0.01% | 6341 |
|
|
2021
Q3 | $41K | Buy |
6,778
+212
| +3% | +$1.28K | ﹤0.01% | 5385 |
|
|
2021
Q2 | $32K | Buy |
6,566
+566
| +9% | +$2.76K | ﹤0.01% | 5770 |
|
|
2021
Q1 | $15K | Sell |
6,000
-3,070
| -34% | -$7.68K | ﹤0.01% | 6597 |
|
|
2020
Q4 | $24K | Sell |
9,070
-9,955
| -52% | -$26.3K | ﹤0.01% | 5791 |
|
|
2020
Q3 | $29K | Buy |
19,025
+2,842
| +18% | +$4.33K | ﹤0.01% | 5158 |
|
|
2020
Q2 | $30K | Sell |
16,183
-2,124
| -12% | -$3.94K | ﹤0.01% | 5417 |
|
|
2020
Q1 | $31K | Sell |
18,307
-6,342
| -26% | -$10.7K | ﹤0.01% | 5287 |
|
|
2019
Q4 | $71K | Sell |
24,649
-17,730
| -42% | -$51.1K | ﹤0.01% | 5130 |
|
|
2019
Q3 | $27K | Buy |
42,379
+42,321
| +72,967% | +$27K | ﹤0.01% | 5583 |
|
|
2019
Q2 | $0 | Sell |
58
-4,520
| -99% | – | ﹤0.01% | 6974 |
|
|
2019
Q1 | $6K | Sell |
4,578
-907,669
| -99% | -$1.19M | ﹤0.01% | 6234 |
|
|
2018
Q4 | $976K | Buy |
912,247
+909,706
| +35,801% | +$973K | ﹤0.01% | 3017 |
|
|
2018
Q3 | $16K | Sell |
2,541
-3,707
| -59% | -$23.3K | ﹤0.01% | 6002 |
|
|
2018
Q2 | $67K | Buy |
6,248
+4,186
| +203% | +$44.9K | ﹤0.01% | 4871 |
|
|
2018
Q1 | $22K | Sell |
2,062
-1,525
| -43% | -$16.3K | ﹤0.01% | 5474 |
|
|
2017
Q4 | $25K | Sell |
3,587
-959
| -21% | -$6.68K | ﹤0.01% | 5411 |
|
|
2017
Q3 | $40K | Buy |
4,546
+1,745
| +62% | +$15.4K | ﹤0.01% | 5061 |
|
|
2017
Q2 | $26K | Sell |
2,801
-2,225
| -44% | -$20.7K | ﹤0.01% | 5166 |
|
|
2017
Q1 | $40K | Buy |
5,026
+1,715
| +52% | +$13.6K | ﹤0.01% | 4778 |
|
|
2016
Q4 | $29K | Buy |
3,311
+801
| +32% | +$7.02K | ﹤0.01% | 5324 |
|
|
2016
Q3 | $43K | Buy |
+2,510
| New | +$43K | ﹤0.01% | 4765 |
|